Martingale Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Sell |
2,598
-8,998
| -78% | -$4.72M | 0.03% | 396 |
|
|
2025
Q1 | $7.35M | Sell |
11,596
-8,612
| -43% | -$5.46M | 0.19% | 132 |
|
|
2024
Q4 | $14.4M | Sell |
20,208
-1,503
| -7% | -$1.07M | 0.35% | 106 |
|
|
2024
Q3 | $22.8M | Sell |
21,711
-4,472
| -17% | -$4.7M | 0.52% | 70 |
|
|
2024
Q2 | $27.5M | Sell |
26,183
-3,279
| -11% | -$3.45M | 0.6% | 57 |
|
|
2024
Q1 | $28.4M | Sell |
29,462
-3,320
| -10% | -$3.2M | 0.57% | 65 |
|
|
2023
Q4 | $28.8M | Sell |
32,782
-1,473
| -4% | -$1.29M | 0.59% | 59 |
|
|
2023
Q3 | $28.2M | Sell |
34,255
-2,097
| -6% | -$1.73M | 0.59% | 60 |
|
|
2023
Q2 | $26.1M | Sell |
36,352
-2,000
| -5% | -$1.44M | 0.51% | 77 |
|
|
2023
Q1 | $31.5M | Sell |
38,352
-527
| -1% | -$433K | 0.61% | 57 |
|
|
2022
Q4 | $28.1M | Sell |
38,879
-3,627
| -9% | -$2.62M | 0.55% | 72 |
|
|
2022
Q3 | $29.3M | Sell |
42,506
-1,829
| -4% | -$1.26M | 0.58% | 63 |
|
|
2022
Q2 | $26.2M | Sell |
44,335
-3,545
| -7% | -$2.1M | 0.48% | 77 |
|
|
2022
Q1 | $33.4M | Sell |
47,880
-3,422
| -7% | -$2.39M | 0.5% | 79 |
|
|
2021
Q4 | $32.4M | Sell |
51,302
-3,054
| -6% | -$1.93M | 0.41% | 95 |
|
|
2021
Q3 | $32.9M | Sell |
54,356
-10,813
| -17% | -$6.54M | 0.43% | 97 |
|
|
2021
Q2 | $36.4M | Sell |
65,169
-3,192
| -5% | -$1.78M | 0.42% | 93 |
|
|
2021
Q1 | $32.3M | Buy |
68,361
+4,498
| +7% | +$2.13M | 0.37% | 102 |
|
|
2020
Q4 | $30.9M | Buy |
63,863
+10,729
| +20% | +$5.18M | 0.35% | 104 |
|
|
2020
Q3 | $29.7M | Buy |
53,134
+12,946
| +32% | +$7.25M | 0.36% | 104 |
|
|
2020
Q2 | $25.1M | Buy |
+40,188
| New | +$25.1M | 0.3% | 114 |
|
|
2019
Q3 | – | Sell |
-1,303
| Closed | -$408K | – | 1045 |
|
|
2019
Q2 | $408K | Sell |
1,303
-1
| -0.1% | -$313 | ﹤0.01% | 917 |
|
|
2019
Q1 | $536K | Buy |
+1,304
| New | +$536K | 0.01% | 880 |
|
|
2018
Q1 | – | Sell |
-603
| Closed | -$227K | – | 978 |
|
|
2017
Q4 | $227K | Sell |
603
-600
| -50% | -$226K | ﹤0.01% | 912 |
|
|
2017
Q3 | $538K | Buy |
+1,203
| New | +$538K | 0.01% | 828 |
|
|
2017
Q1 | – | Sell |
-4,615
| Closed | -$1.7M | – | 979 |
|
|
2016
Q4 | $1.7M | Sell |
4,615
-310
| -6% | -$114K | 0.02% | 589 |
|
|
2016
Q3 | $1.98M | Buy |
4,925
+50
| +1% | +$20.1K | 0.03% | 513 |
|
|
2016
Q2 | $1.7M | Buy |
4,875
+495
| +11% | +$173K | 0.03% | 359 |
|
|
2016
Q1 | $1.58M | Buy |
4,380
+140
| +3% | +$50.5K | 0.03% | 370 |
|
|
2015
Q4 | $2.3M | Buy |
4,240
+500
| +13% | +$271K | 0.05% | 290 |
|
|
2015
Q3 | $1.74M | Buy |
3,740
+1,740
| +87% | +$810K | 0.04% | 333 |
|
|
2015
Q2 | $1.02M | Buy |
2,000
+925
| +86% | +$472K | 0.02% | 508 |
|
|
2015
Q1 | $486K | Buy |
1,075
+300
| +39% | +$136K | 0.01% | 711 |
|
|
2014
Q4 | $318K | Buy |
+775
| New | +$318K | 0.01% | 770 |
|